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Vitiligo is characterized by a substantial loss of functional melanocytes in the epidermis and sometimes in hair follicles. Genetic and pathophysiological studies have provided strong evidence that vitiligo is a polygenetic, multifactorial disorder.
The key roles of oxidative stress within melanocytes and anti-melanocyte immune responses have been addressed in many studies, but the relationship between these mechanisms remains unclear. In this issue, Toosi et al. report the upregulation of IL-6 and IL-8 after the activation of the unfolded protein response (UPR) following exposure of melanocytes to phenols. Their results shed light on the missing link between oxidative stress and immune responses in vitiligo. (Alkhateeb et al., 2003) . Environmental triggers thus appear mandatory at least to initiate the immune process. In this respect, we hypothesized that the activation of XBP1 in response to the oxidative stress induced by phenols, as reported in this issue by Toosi et al. (2012) , could be enhanced in subjects with specific allelic variations in the XBP1 gene. Variations in other candidate genes involved in immune regulation could act in the same way in affected individuals to initiate an immune ''runaway''. Interestingly, some variants of TYR (S192Y and R402Q) have recently been shown to modulate the amount of TYR antigen presentation by HLA-A * 02:01 (Jin et al., 2012) . These variants are associated with an increased risk of vitiligo, whereas HLA-A * 02:01 is also associated with a relatively good response to melanoma immunotherapy. Monobenzone exposition was also shown to confer potent immunogenicity. Ubiquitination of tyrosinase protein by monobenzone exposure enhances the presentation of this enzyme by HLA class I and the secretion of melanocyte antigens in response to monobenzoneinduced ROS (van den Boorn et al., 2011) . These data suggest that modulation in the presentation of melanocyte antigens could also affect the deregulated immune responses against melanocytes in patients.
Vitiligo pathogenesis includes interplay among oxidative stress and immunity.
A complex network with many cellular factors involved
Aside from the well-demonstrated role of immune cells in vitiligo pathophysiology, cytokines produced by keratinocytes and fibroblasts, such as stem cell factor (SCF) and tumor necrosis factor-a (TNF-a), also seem to have roles in the disappearance of melanocytes (Lan et al., 2009) . Keratinocyte dysfunction, with increased TNF-a and IL-6 production, has been reported in vitiligo patients (Moretti et al., 2009) . Interestingly, tacrolimus ointment, an effective treatment for vitiligo, was shown to decrease TNF-a and to increase IL-10 (a Th1 and Th17 suppressive cytokine) within treated sites (Grimes et al., 2004; Taher et al., 2009) . SCF is secreted by keratinocytes and fibroblasts. The expression of SCF and its receptor, cKIT, is decreased in lesional and perilesional vitiligo skin (Kitamura et al., 2004) , and vitiligo-like depigmentation has been reported in relation to tyrosine kinase inhibitors such as imatinib, which act on the cKIT pathway (Legros et al., 2005) . Last but not the least, intrinsic defects in melanocytes probably have a crucial role in the pathophysiology of vitiligo. Membrane lipid defects in vitiligo melanocytes have been reported, and they are responsible for the generation of reactive oxygen species (Dell'Anna et al., 2010) . It would be interesting to know whether this type of intrinsic oxidative stress also activates the UPR and upregulates IL-6 and IL-8, thus resuming the pathway implicated with exposure to phenols. We could hypothesize that subtle defects in melanocyte catabolism, in defense against oxidative stress, or in melanocyte antigen presentation, affecting only a subgroup of melanocytes during embryogenesis, could, later in life, trigger an immune response against only those melanocytes. This could explain the systematized lesions observed in the segmental forms of vitiligo. A scheme summarizing those interplays is proposed in Figure 1 .
Vitiligo is not limited to melanocytes, even though their disappearance is responsible for the clinical phenotype. Upregulation of IL-6 and IL-8 following activation of the UPR after oxidative stress provides a clear link between oxidative stress and the immune response. A better understanding of these mechanisms could provide new targets to prevent or treat patients with vitiligo.
